The term collision tumor refers to the coexistence of two adjacent but histological distinct tumors with no histological admixture at the interface. Collision tumors involving ovaries are extremely rare. A collision tumor composed of a dermoid cyst and fibrothecoma is extremely rare in menopausal women. The mechanism of the development of collision tumor is uncertain. During clinical evaluation, differentiation of characters of these ovarian tumors is important to decide appropriate treatment strategies and for good prognosis. We report an unusual clinical manifestation of the torsion of a dermoid cyst and fibrothecoma in the right ovary with postmenopausal bleeding. (J Menopausal Med 2016;22:114-117)
Introduction
Dermoid cysts are the most frequently occurring tumors among ovarian germ cell tumors, accounting for more than 20% of all ovarian neoplasms. 1 They present most commonly in women younger than 20 years of age, but sometimes occur in menopausal women at a rate of about 10% to 20%.
Fibrothecomas are ovarian tumors of gonadal stromal origin, mesenchymal cell tumors composed of theca-like elements and fibrous tissue, and account for about 0.4% to 8% of all ovarian tumors. 2 A collision tumor is defined as a tumor in which the different neoplastic components remain histologically distinct and are separated from each other by narrow stroma or their respective basal lamina.
We report the case of a 77 year old woman who presented with postmenopausal bleeding (PNB) due to the torsion of a collision tumor comprising a dermoid cyst and fibrothecoma.
Case Report
A 77-year-old postmenopausal woman presented with vaginal bleeding with a week-long history and a large pelvic mass associated with lower abdominal discomfort for 3 months. The patient complained of pain, but had no fever, chills and significant gastrointestinal symptoms. She had gone through menopause at the age of 52 and was not taking any hormone replacement.
She had no significant past medical history, familial history or operation history. On pelvic examination, a relatively hard, movable, non-tender mass as large as a double man' s fist was palpated on the right lower abdomen.
The vagina, cervix and uterus were normal. There was no guarding or rebound tenderness. Abdominal magnetic resonance imaging (MRI) showed a 12 × 12 × 11.5 cm sized, well-marginated, bilobulated cystic mass with some solid areas in the right pelvic cavity.
With enhancement setting, the mass exhibited relatively high enhancement and heterogenicity (Fig. 1) . There was no other abnormal finding on images and no pelvic lymph node enlargement was observed.
Endometrial aspiration was done, confirming historically normal proliferative endometrium.
Under general anesthesia, surgical exploration was performed with a suspicion of ovarian tumor. PMB is vaginal bleeding that occurs at least 12 months after your periods have stopped. PMB is a common problem representing 5% of all gynecology outpatient attendances. 4 The most common causes of bleeding after menopause include thinning of the reproductive tract tissues and hormone therapy. 5 In some cases, bleeding can signal cancer of the uterine lining or cervical cancer. Other possible causes include fibroids, small growths in the uterus or cervix, known as polyps, and ovarian cancer, especially estrogen-secreting ovarian tumors. Although most women with PMB will not have significant pathology, the priority is to exclude malignancy. 
Conclusion
This study shows that the hormonal changes caused by sex cord stromal tumor can cause postmenopausal uterine bleeding and can have significant influence on collision tumors involving dermoid cysts and fibrothecoma. The torsion of this kind of unique combination of tumors has never been reported, thus this study has its remarkability.
